Mrs. Michelle Marie Kroeger, ARNP, MSN Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 221 Ann St, Manning, IA 51455 Phone: 712-653-2211 |
Mrs. Brittany Janae Bremser, ARNP Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 1550 6th St, Manning, IA 51455 Phone: 712-655-2072 |
Beth Anne Hill, ARNP Nurse Practitioner - Psych/Mental Health Medicare: Not Enrolled in Medicare Practice Location: 3976 Highway 141, Manning, IA 51455 Phone: 712-653-2120 |
Taya Nicole Vonnahme, ARNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1550 6th St, Manning, IA 51455 Phone: 712-655-8108 |
Sara Marie Powers, Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 1550 6th St, Manning, IA 51455 Phone: 402-398-6060 |
News Archive
Drugs called ion channel blockers, which are commonly used to treat cardiac, neurological, and psychiatric disorders, might prove useful in cancer therapy, according to research findings in fruit flies and mice by UC San Francisco scientists that led to unconventional treatment of a case of metastatic brain cancer.
IDM Pharma, Inc. ( NASDAQ:IDMI ) announced today that it received a not approvable letter from the U.S. Food and Drug Administration (FDA) after completing the review of the new drug application (NDA) for the investigational drug mifamurtide (L-MTP-PE), formerly known as Junovan, for the treatment of non-metastatic osteosarcoma, a rare and often fatal bone tumor that typically affects children and young adults.
An addiction is an addiction and it may be tougher to quit smoking cigarettes compared to beating a heroin addiction. An Australian study found that many long term smokers have tried to quit 7.4 times but are still unable to do so. Sydney GP Raymond Seidler actually feels that people do not realize that quitting smoking is just as bad as kicking heroin out of your life.
A nasal vaccine in development by researchers at The University of Texas at Austin has been shown to provide long-term protection for non-human primates against the deadly Ebola virus. Results from a small pre-clinical study represent the only proof to date that a single dose of a non-injectable vaccine platform for Ebola is long-lasting, which could have significant global implications in controlling future outbreaks.
› Verified 6 days ago